NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Van Etten and colleagues showed in mouse models of CML and Ph+ B-ALL that NF-κB contributes to myeloid and lymphoid leukemogenesis through Bcr-Abl [76].